Astera Labs vs. Applied Materials: Which Technology Stock Is a Better Buy in 2026?

Applied Materials is favored over Astera Labs for long-term investors due to its lower valuation, trading at 26.3x forward P/E and 12.2x sales versus Astera's 43.9x and 43.0x, respectively. Astera delivered FY2025 revenue growth of approximately 115% to $853 million and posted Q2 2026 revenue of $392.4 million, up 104% year over year, but faces material customer-concentration risk, with one customer contributing more than 70% of revenue. Applied Materials reported fiscal Q3 2026 revenue growth of 25% to $9.1 billion and net-income growth of 43%, while consensus expects FY2026 revenue of $34.3 billion (+21%) and net income growth of 50%.

Analysis

The relevant distinction is not AI exposure but where each company sits in the capex chain. ALAB monetizes an incremental increase in accelerator/rack complexity immediately, but its revenue base remains vulnerable to qualification changes, internal silicon programs, and a single hyperscaler’s platform transition; at its valuation, even a modest deceleration in quarterly sequential growth could drive disproportionate multiple compression. Its reported cash generation should be normalized for stock compensation before assigning it a premium “FCF compounder” multiple.

AMAT offers a more durable, diversified way to express sustained AI-led semiconductor investment because leading-edge logic, HBM, and advanced packaging each require process-intensity gains, not merely higher wafer volumes. The less obvious upside is that a shift toward custom AI ASICs by AMZN and other hyperscalers broadens foundry and packaging demand, supporting AMAT even if GPU share rotates away from NVDA. The principal near-term offset is China: any further export-control tightening can impair service revenue and tool utilization, while the recent compliance settlement raises the probability that regulators scrutinize order routing more aggressively.

Over the next 1-3 months, the ALAB/AMAT relative outcome will hinge on hyperscaler 2027 capex commentary and whether ALAB can demonstrate that new programs reduce concentration rather than simply add products within the same account. Over 6-18 months, AMAT’s earnings durability depends on advanced-node and packaging WFE staying elevated after memory’s current recovery cycle. Consensus may be too quick to treat AMAT as a low-growth value proxy: sustained process complexity can support a higher through-cycle earnings base, but only if China exposure is replaced by non-China demand rather than deferred.

The cleaner expression is relative rather than an outright AI-beta purchase: AMAT has valuation support and broader end-market optionality, while ALAB embeds a much narrower execution band. This thesis is falsified if ALAB discloses a material reduction in customer concentration while maintaining growth and gross margin, or if AMAT guides to a meaningful China-driven service/order decline despite robust leading-edge demand.

Key Decisions for Investors

• Initiate a 6-12 month long AMAT / short ALAB dollar-neutral pair on strength in AI hardware; target 15-20% relative return. Use a 10% adverse relative-performance stop, particularly if ALAB reports a second large customer or raises full-year growth without margin dilution.
• Add AMAT ahead of the next earnings print only if management confirms non-China logic, HBM, and advanced-packaging orders are offsetting China restrictions; trim if China-related revenue or service guidance is cut by more than 5%.
• Avoid outright ALAB longs until the next filing quantifies concentration improvement and provides evidence of design-win conversion beyond its dominant account. A miss in sequential revenue growth or gross-margin guidance is a catalyst for a 20%+ valuation reset given the current premium multiple.
• Monitor AMZN, MSFT, GOOGL, and META capex guidance as the primary read-through: accelerating custom-silicon and data-center build plans favor AMAT’s broader WFE exposure, while a rack-level interconnect spending surge without additional foundry capacity would favor ALAB.